Funding for this research was provided by:
Institutional Development Award (P20GM1033408, 4U54GM104944-04TBD)
National Institute of Mental Health (1R44MH112210-01A1)
University of Idaho Vandal Ideas Project
National Institute of Neurological Disorders and Stroke Grant (R01NS111283)
Received: 10 January 2020
Accepted: 6 March 2020
First Online: 16 March 2020
Ethics approval and consent to participate
: In this study, all the MRI data collection development was approved by the local institutional review board in Amiens, France and satisfied all local and international regulations for human subject research. All data was de-identified before transferring to the University of Idaho for further analysis.
: All authors have approved the manuscript submission. The content of this manuscript has not been published or submitted for publication elsewhere.
: BAM has received research funding from Biogen Inc., KBR Wyle, Alcyone Lifesciences Inc., Minnetronix Inc., and Voyager Therapeutics.